263 related articles for article (PubMed ID: 10693883)
1. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.
Watts RA; Lane SE; Bentham G; Scott DG
Arthritis Rheum; 2000 Feb; 43(2):414-9. PubMed ID: 10693883
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
[TBL] [Abstract][Full Text] [Related]
3. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe.
Watts RA; Gonzalez-Gay MA; Lane SE; Garcia-Porrua C; Bentham G; Scott DG
Ann Rheum Dis; 2001 Feb; 60(2):170-2. PubMed ID: 11156552
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.
Mohammad AJ; Jacobsson LT; Mahr AD; Sturfelt G; Segelmark M
Rheumatology (Oxford); 2007 Aug; 46(8):1329-37. PubMed ID: 17553910
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales.
Ormerod AS; Cook MC
Intern Med J; 2008 Nov; 38(11):816-23. PubMed ID: 18771432
[TBL] [Abstract][Full Text] [Related]
6. Primary renal vasculitis in Norfolk--increasing incidence or increasing recognition?
Lane SE; Scott DG; Heaton A; Watts RA
Nephrol Dial Transplant; 2000 Jan; 15(1):23-7. PubMed ID: 10607763
[TBL] [Abstract][Full Text] [Related]
7. Primary systemic vasculitis with severe α1-antitrypsin deficiency revisited.
Mohammad A; Segelmark M
Scand J Rheumatol; 2014; 43(3):242-5. PubMed ID: 24313382
[TBL] [Abstract][Full Text] [Related]
8. Classification and epidemiology of the vasculitides.
Watts RA; Scott DG
Baillieres Clin Rheumatol; 1997 May; 11(2):191-217. PubMed ID: 9220075
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of systemic vasculitis: changing incidence or definition?
Watts RA; Carruthers DM; Scott DG
Semin Arthritis Rheum; 1995 Aug; 25(1):28-34. PubMed ID: 8525388
[TBL] [Abstract][Full Text] [Related]
10. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.
Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL
Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
Gibson A; Stamp LK; Chapman PT; O'Donnell JL
Rheumatology (Oxford); 2006 May; 45(5):624-8. PubMed ID: 16368729
[TBL] [Abstract][Full Text] [Related]
12. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.
Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862
[TBL] [Abstract][Full Text] [Related]
14. Are environmental factors important in primary systemic vasculitis? A case-control study.
Lane SE; Watts RA; Bentham G; Innes NJ; Scott DG
Arthritis Rheum; 2003 Mar; 48(3):814-23. PubMed ID: 12632437
[TBL] [Abstract][Full Text] [Related]
15. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
Mohammad AJ; Jacobsson LT; Westman KW; Sturfelt G; Segelmark M
Rheumatology (Oxford); 2009 Dec; 48(12):1560-5. PubMed ID: 19797309
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.
Watts R; Lane S; Hanslik T; Hauser T; Hellmich B; Koldingsnes W; Mahr A; Segelmark M; Cohen-Tervaert JW; Scott D
Ann Rheum Dis; 2007 Feb; 66(2):222-7. PubMed ID: 16901958
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients.
Panagiotakis SH; Perysinakis GS; Kritikos H; Vassilopoulos D; Vrentzos G; Linardakis M; Bertsias G; Glaser K; Daphnis E; Boumpas DT
Clin Exp Rheumatol; 2009; 27(3):409-15. PubMed ID: 19604432
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Vasculitides in Khorasan Province, Iran.
Jokar M; Mirfeizi Z
Iran J Med Sci; 2015 Jul; 40(4):362-6. PubMed ID: 26170524
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Sørensen diagnostic criteria in the classification of systemic vasculitis.
Lane SE; Watts RA; Barker TH; Scott DG
Rheumatology (Oxford); 2002 Oct; 41(10):1138-41. PubMed ID: 12364633
[TBL] [Abstract][Full Text] [Related]
20. Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis.
Chanseaud Y; Tamby MC; Guilpain P; Reinbolt J; Kambouchner M; Boyer N; Noël LH; Guillevin L; Boissier MC; Mouthon L
J Autoimmun; 2005 Mar; 24(2):169-79. PubMed ID: 15829409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
